Purpose: To describe a novel point mutation in the initiation codon of the XLRS1 gene in a large family and the clinical features of males affected with X-linked juvenile retino-schisis.
Methods: Genealogic investigation and mutation screening of the XLRS1 gene were performed for a 4-generation family consisting of 72 members. Affected males were evaluated clinically between 1986 and 2004 with up to 18 years of follow-up.
Results: We identified a novel point mutation (1A>T transversion) in the initiation codon of the XLRS1 gene in affected males resulting in an amino acid substitution of methionine to leucine (Met1Leu), therefore abolishing the translation initiation Met codon.
Conclusion: Identification of the disease-causing mutation in this family with long-term follow-up allows for earlier and more accurate identification of individuals at risk for this inherited progressive macular degeneration, provides for more accurate genetic counseling, and contributes to our understanding of the pathophysiology of this disorder.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.iae.0000224321.93502.a3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multimodal imaging in a pedigree of X-linked Retinoschisis with a novel RS1 variant.
BMC Med Genet
November 2018
The Catherine McAuley Centre, Mater Private Hospital, Nelson Street, Dublin 7, Ireland.
Background: To describe the clinical phenotype and genetic cause underlying the disease pathology in a pedigree (affected n = 9) with X-linked retinoschisis (XLRS1) due to a novel RS1 mutation and to assess suitability for novel therapies using multimodal imaging.
Methods: The Irish National Registry for Inherited Retinal Degenerations (Target 5000) is a program including clinical history and examination with multimodal retinal imaging, electrophysiology, visual field testing and genetic analysis. Nine affected patients were identified across 3 generations of an XLRS1 pedigree.
Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis.
Hum Gene Ther
April 2012
Pharmacokinetics, Nanotechnology and Gene Therapy Group Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.
The goal of the present study was to analyze the potential application of nonviral vectors based on solid lipid nanoparticles (SLN) for the treatment of ocular diseases by gene therapy, specifically X-linked juvenile retinoschisis (XLRS). Vectors were prepared with SLN, dextran, protamine, and a plasmid (pCMS-EGFP or pCEP4-RS1). Formulations were characterized and the in vitro transfection capacity as well as the cellular uptake and the intracellular trafficking were studied in ARPE-19 cells.
View Article and Find Full Text PDF[X linked retinoschisis, unusual presentation: strabismus].
Arch Soc Esp Oftalmol
October 2011
Unidad de Oftalmología, Hospital San Eloy, Baracaldo, Vizcaya, España.
Case Report: X linked retinoschisis is a recessively inherited degenerative retinopathy. We report two cases that debuted with an unusual presentation (strabismus) in early childhood (months). Both of them presented with vitreous veils in the retinal periphery.
View Article and Find Full Text PDFRegulation of retinoschisin secretion in Weri-Rb1 cells by the F-actin and microtubule cytoskeleton.
PLoS One
December 2011
Jules Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Retinoschisin is encoded by the gene responsible for X-linked retinoschisis (XLRS), an early onset macular degeneration that results in a splitting of the inner layers of the retina and severe loss in vision. Retinoschisin is predominantly expressed and secreted from photoreceptor cells as a homo-oligomer protein; it then associates with the surface of retinal cells and maintains the retina cellular architecture. Many missense mutations in the XLRS1 gene are known to cause intracellular retention of retinoschisin, indicating that the secretion process of the protein is a critical step for its normal function in the retina.
View Article and Find Full Text PDFMutations in the XLRS1 gene in Thai families with X-linked juvenile retinoschisis.
Jpn J Ophthalmol
January 2010
Department of Ophthalmology, Siriraj Hospital Mahidol University, Bangkok, Thailand.
Purpose: To identify genetic mutations of the XLRS1 gene and to describe the ocular phenotypes in two unrelated Thai patients with X-linked juvenile retinoschisis.
Methods: Ophthalmic examination, including best-corrected visual acuity and fundus examination and photography, was performed in all participants. Electroretinography (ERG) and optical coherence tomography were performed when possible.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!